Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
about
Stopping long-acting beta 2 -agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroidsStopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroidsStopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroidsStopping long-acting beta2-agonists (LABA) for adults with asthma well-controlled on LABA and inhaled corticosteroidsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsRegular treatment with salmeterol for chronic asthma: serious adverse eventsPharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhageCardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative StressMiniaturized iPS-Cell-Derived Cardiac Muscles for Physiologically Relevant Drug Response Analyses.The mechanism of salbutamol-induced hypokalaemia.Beta adrenoreceptor subtype cross regulation in the human heart.Delayed recognition of fatal invasive meningococcal disease in adultsHyperkalemia.Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies.Analytic review: thyrotoxic periodic paralysis: a review.Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.Hypokalaemia and hyperkalaemia.Out-of-hospital cardiac arrest in patients without clinically significant coronary artery disease: comparison of clinical, electrophysiological, and survival characteristics with those in similar patients who have clinically significant coronary artHypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention.Beta-adrenoceptors and human skeletal muscle characterisation of receptor subtype and effect of age.Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1-adrenoceptor antagonists.Hyperkalemia: a review.Noradrenaline: a circulating inhibitor of sodium transport.Effect of cetamolol on epinephrine-induced hypokalemia.Digitalis: where are we now?Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisitedInhaled beta 2-adrenoceptor agonists in asthma: help or hindrance?Metabolic effects of beta 2-agonists.Effect of diabetes on serum potassium concentrations in acute coronary syndromes.Epinephrine facilitates neurogenic vasoconstriction in humansThe dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potentialLactic acidosis associated with the usual theophylline dose in a patient with asthma.Blood electrolyte disturbances during severe hypoglycemia in Korean patients with type 2 diabetesElectrocardiographic characteristics of potential organ donors and associations with cardiac allograft useHypokalemic Paralysis Complicated by Concurrent Hyperthyroidism and Chronic Alcoholism: A Case Report.Pharmacodynamic responses of exogenous epinephrine during mandibular third molar surgery.
P2860
Q24187082-781F3FB6-C9B5-4636-8CC7-0A9E136FF405Q24187884-B0AF0D2A-4AB3-497D-8318-EC4074B70C7CQ24193977-3A655F08-2364-4D94-9054-F12148267EF4Q24194037-6C740866-CC72-41A8-A259-1CA30244B3CCQ24200353-4AF4B4E7-E8E7-4B37-A6C9-3761D5B67211Q24201048-85022183-EE89-4A7E-9F68-94B3EAA3B49BQ24241960-7907EE8D-D139-4DC5-9924-8635FBD69F79Q24540330-AB24741E-9259-4BE2-A6FF-EEF99BA41DEEQ24794812-15018126-8567-4A1F-B066-E5F967365636Q26773004-E8BA9CAA-6828-4A24-9387-EF7E1FC1F926Q27320368-7259BD88-5BED-4D1B-9D4D-50207A942232Q28361752-FE53CF09-D6CF-4579-9402-CF4B9CA6F636Q28369498-008A20EC-6C36-4DD0-BB7A-D2C5EF49F961Q33440465-C2524484-EA9E-4356-9B52-8CD2EE197F9DQ33581352-13F183DC-C350-4177-86C6-2303F6455528Q33620311-3B53B3E2-3A6E-456E-90E4-138DEFB09ACAQ34019056-E61A9179-02A9-415F-ADC7-A7D922E5C2DEQ34020920-21E57ED5-CEE4-46AB-AB85-4031675AD9AFQ34061092-4DA84B9C-6E61-4439-BACD-59B12009CB2DQ34103327-6CEEEA30-299C-4C8B-A25E-743A8CB567F7Q34118621-2D2F039D-4D25-4F72-927C-13AA00CACDACQ34163348-8B24BF49-5A44-4CFC-A460-660E8ECC31FCQ34396952-81CF4341-6BF2-4BF5-99B4-1DBC3204515AQ34397642-89AD8EE0-91EE-4B88-8C6B-A2EA5E0B8661Q34421115-6B41B105-26A4-463B-8AE1-69F7DD34C55FQ34448823-C7BB4767-4EA5-40E4-91B2-1F098165ED15Q34552899-7DC53821-292C-46A6-99E7-0554E780A9ECQ34560829-CD553D34-3406-422B-9855-8A83BEAE7981Q34695599-04BE6BA2-4D4D-408D-9FB6-9A13A00E7143Q35138063-89E88189-D415-4B02-A6C2-F3A60818BD5CQ35252017-D6EA1B64-B70F-4264-8AF6-446795427CD3Q35261267-AD366018-DFFD-447F-B2B4-3889BF734D1DQ35580721-619476BB-0C4A-428A-8FE1-40669A52617AQ35811926-2525FCFC-0734-4D73-836A-80403FC928A1Q35874322-4A8C5F3F-24F2-400A-A39B-4BF193CACBC0Q35937355-226317DB-70E7-4944-9818-7D47B2D2D4A3Q36081194-24BEFA60-D47B-419D-9424-F91AD4D697A9Q36105156-B2CD595B-916F-42BB-B26E-48815DC8C20AQ36195744-D323666A-E3F5-4109-A60A-8C750E70782BQ36307486-F7325B36-7AC6-41D1-A3E9-807DEF54BDB8
P2860
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
@en
type
label
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
@en
prefLabel
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
@en
P2093
P1476
Hypokalemia from beta2-receptor stimulation by circulating epinephrine.
@en
P2093
P304
P356
10.1056/NEJM198312083092303
P407
P577
1983-12-01T00:00:00Z